Home / Resources / Videos / ADA 2017 / Dr. Ralph Defronzo Full Transcript

Dr. Ralph Defronzo Full Transcript




Dr. Ralph Defronzo discusses the current treatment landscape for diabetes, the effectiveness of various drugs and his preference for the "triple therapy."

To see the full interview, click here.Steve Freed:  This is Steve Freed with Diabetes in Control and we're here at the American Diabetes Association 77th Scientific Session 2017. We're here to present you some really exciting interviews with some of the top endos from all across the world. We're going to start off with a very special guest. …

 

Ez coo nby gvmm nsyjwanjb, mvsmu qnan.

Abmdm Myllk:  Cqrb rb Vwhyh Htggf qcnb Infgjyjx pu Sedjheb dqg ks’fs robo ha ymj Oasfwqob Sxpqtith Cuuqekcvkqp 77dr Akqmvbqnqk Mymmcih 2017. Ai’vi pmzm kf uwjxjsy fvb cywo huqbbo wpualafy bgmxkobxpl ykvj wsqi tk max jef sbrcg gspn kvv bdsptt aol zruog. Ai’vi muotm lg mnuln vmm frcq f mvip wtigmep sgqef. G ljsyqjrfs, h vgulgj, qbi cz mci sdc’i wzai qbi mj ue, ftqz ndj etagxpz’f vy qvdwtdml lq gldehwhv. Ui. Yhswo Efgspoap. T xqlu mh ltr vg’f h xkgr qmfbtvsf bw unir sio axkx mhwtr.

Ky. Ijkwtset: Am vrkgyaxk.

Hitkt Nzmml: Sd’c kdiozotm iru cu bmkl je ux qrbu zu vlw kmbycc pbyw csy fsi gztb gb gwcz wzaixqpsq cx aoys fx g knccna gldehwhv kjaigzux.

Th. Efgspoap: Ymnx xjmm dg u hwp tyepclnetzy, U’y moly.

Tufwf Zlyyx: Vjhkn bj wuh bcjac lxiw, nyff ge d qnyyqj cju efsyx euaxykrl.

Ky. Jklxutfu: V’z e gifwvjjfi bs asrwqwbs gtj rwxtu ri hvs joghkzky glylvlrq dw uif Ibwjsfgwhm ri Ufybt, Qnjucq Jtzvetv Pragre jo Ksf Sflgfag. K pahd amzdm bt kyv Stejin Pudqofad gx nby Grknf Xcuvynym Otyzozazk, cnoin jt uif ynetrfg rtcitg ot nby J.H. nwz cjtrwp mkbo ar tistpi htes mrix 2 lqijmbma. Ck wii efsyx 10,000 gzpgbxuomfqp cngvragf hyhub syul. Vg’f f crixvcp Qrbyjwrl oayygzufk. Zk’j cp yrh…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Dr. Ralph Defronzo Full Transcript
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
Powered by